Navigation

Mountainview Consulting Group
Home

Mountainview Menu

  • Home
  • Services
    • Endorsements
  • About
  • Contact
  • Books
    • In This Moment
    • Inside This Moment
    • Behavioral Consultation and Primary Care, Second Edition
    • Behavioral Consultation and Primary Care
    • Brief Interventions for Radical Change
    • Real Behavior Change in Primary Care
    • The Mindfulness & Acceptance Workbook for Depression (Second Edition)
    • Basics of Behavior Change in Primary Care
  • Videos
    • FACT
    • Primary Care How-To
  • News
  • Blog
    • Focused Acceptance and Commitment Therapy
    • Primary Care Behavioral Health
Return to Content

U.S. FDA to Pull Opana ER, Powerful Opioid from Market

By Bridget Beachy on June 10, 2017 in Healthcare News

“The US Food and Drug Administration said Thursday that drugmaker Endo Pharmaceuticals must remove its powerful opioid painkiller Opana ER from the market.”  Follow the link for more details! Stay strong FDA.

http://www.cnn.com/2017/06/08/health/fda-opioid-opana-er-bn/index.html?sr=fbCNN060917fda-opioid-opana-er-bn0230AMVODtopLink&linkId=38513964

Dr. Beachy Completes 1 year Fellowship
#MCG on Social Media

Categories

  • Focused Acceptance and Commitment Therapy
  • Healthcare News
  • Healthcare Transformation
  • News
  • Primary Care Behavioral Health

Recent Posts

  • Teaching in Copenhagen, Denmark and Working with the FACT Summer Campers in Sweden
  • Montana Primary Care Association
  • Praxis FACT Lab
  • Ireland Mastery Course
  • Skills vs. Pills

© 2023 Mountainview. All Rights Reserved.

Hosted locally at Portland's Host Pond Web Hosting